Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Balance Sheets

v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 18,920 $ 26,674
Restricted deposit 236 241
Trade receivables, net 250
Inventories 439 714
Other accounts receivable and prepaid expenses 490 393
Total current assets 20,335 28,022
Non-current assets:    
Restricted deposit 113 57
Operating lease right-of-use assets 3,398 3,070
Property and equipment, net 2,561 2,789
Intangible assets, net 159 188
Total non-current assets 6,231 6,104
Total assets 26,566 34,126
Current liabilities:    
Trade payables 1,138 980
Operating lease liabilities 789 624
Accrued liabilities and other 1,314 1,647
Total current liabilities 3,241 3,251
Non-current liabilities:    
Operating lease liabilities 2,596 2,535
Total non-current liabilities 2,596 2,535
Total liabilities 5,837 5,786
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2024 (unaudited) and December 31, 2023; issued and outstanding: 11,454,512 and 11,452,672 ordinary shares as of June 30, 2024 (unaudited) and December 31, 2023, respectively 4,983 4,982
Additional paid in capital 121,861 121,068
Accumulated other comprehensive loss (969) (969)
Accumulated deficit (105,146) (96,741)
Total shareholders’ equity 20,729 28,340
Total liabilities and shareholders’ equity $ 26,566 $ 34,126